BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1709707)

  • 1. [Photocoagulation and vitrectomy of diabetic retinopathy].
    Okano T
    Nihon Rinsho; 1991 Feb; 49 Suppl():301-6. PubMed ID: 1709707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic maculopathy and proliferative retinopathy: their relation and the results of photocoagulation].
    Nikolić Lj; Radović N
    Srp Arh Celok Lek; 1985 Aug; 113(8):655-63. PubMed ID: 2418513
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML; Landers MB
    Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced proliferative diabetic retinopathy: photocoagulation or vitrectomy?
    Freyler H; Klemen U; Prskavec F; Egerer I
    Metab Pediatr Ophthalmol; 1980; 4(3):129-32. PubMed ID: 6161281
    [No Abstract]   [Full Text] [Related]  

  • 6. Photocoagulation in diabetic retinopathy: III. Complications.
    Townsend C; Hamilton AM; Cheng H
    Int Ophthalmol Clin; 1978; 18(4):121-31. PubMed ID: 721380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for diabetic retinopathy using photocoagulation and vitrectomy].
    Sato Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():977-81. PubMed ID: 9392228
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1987; 85():176-94. PubMed ID: 2451871
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular oxygenation and the treatment of diabetic retinopathy.
    Stefánsson E
    Surv Ophthalmol; 2006; 51(4):364-80. PubMed ID: 16818083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy: current concepts and emerging therapy.
    Rosberger DF
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):721-45. PubMed ID: 24286948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subretinal neovessels of the posterior pole after pan-photocoagulation for diabetic retinopathy].
    Bacin F; Pujo-Chincholle A
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1385-6, 1388. PubMed ID: 2438061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphological changes in the retina and choroid following photocoagulation (author's transl)].
    Deufrains A; Dietze U; Brandt HP
    Klin Oczna; 1981; 83(4-5):201-2. PubMed ID: 7311371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ophthalmic therapy for diabetic retinopathies--special reference to photocoagulation and vitrectomy].
    Sato Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():178-82. PubMed ID: 12430226
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitrectomy and endolaser photocoagulation in diabetic retinopathy].
    Pauleikhoff D; Gerke E
    Fortschr Ophthalmol; 1987; 84(6):611-3. PubMed ID: 2449383
    [No Abstract]   [Full Text] [Related]  

  • 15. Supplementary peripheral photocoagulation in the treatment of proliferative diabetic retinopathy.
    Boniuk I; Johnston GP; Arribas NP; Escoffery RF
    Mod Probl Ophthalmol; 1979; 20():401-6. PubMed ID: 95032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Photocoagulation and vitrectomy in neovascular proliferative retinopathy].
    Bonnet M; Grange JD
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1399-406. PubMed ID: 2438062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limitation of photocoagulation in diabetic neoproliferative retinopathy as a function of the patients' age].
    Vallat M; Reynaud X; Salomon JL; Lhomme C; Duprat F; Mathon C
    Bull Soc Ophtalmol Fr; 1990; 90(8-9):761-4. PubMed ID: 2257649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitrectomy for treatment of ocular complications in diabetes. III. Factors influencing results of vitrectomy].
    Dziegielewski K; Nawrocki J
    Klin Oczna; 1998; 100(3):143-9. PubMed ID: 9813996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up.
    Theodossiadis GP; Ismiridis KJ
    Fortschr Ophthalmol; 1987; 84(5):465-7. PubMed ID: 2448214
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of panretinal photocoagulation in preproliferative and proliferative ischemic diabetic retinopathy: apropos of 235 eyes followed for 6 months to 8 years].
    Annonier MP; Soubrane G; Coscas G
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1363-6. PubMed ID: 2438059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.